Stock analysts at Evercore ISI initiated coverage on shares of athenahealth (NASDAQ:ATHN) in a research note issued to investors on Thursday, The Fly reports. The brokerage set a $140.00 price target on the health services provider’s stock. Evercore ISI’s price objective would suggest a potential upside of 10.95% from the stock’s current price.

A number of other research firms have also recently issued reports on ATHN. BidaskClub cut athenahealth from a “hold” rating to a “sell” rating in a research report on Tuesday. KeyCorp reiterated a “buy” rating and issued a $152.00 target price on shares of athenahealth in a research report on Friday, January 12th. Citigroup initiated coverage on athenahealth in a research report on Thursday, January 4th. They issued a “neutral” rating on the stock. Oppenheimer reiterated a “buy” rating and issued a $184.00 target price on shares of athenahealth in a research report on Friday, October 20th. Finally, Canaccord Genuity reiterated a “hold” rating and issued a $123.00 target price (down previously from $144.00) on shares of athenahealth in a research report on Monday, October 23rd. Two equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $142.96.

athenahealth (NASDAQ ATHN) traded down $2.03 during mid-day trading on Thursday, reaching $126.18. The company’s stock had a trading volume of 551,800 shares, compared to its average volume of 407,582. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35. athenahealth has a 1 year low of $95.01 and a 1 year high of $158.66. The company has a market cap of $5,050.00, a PE ratio of 163.87, a price-to-earnings-growth ratio of 3.00 and a beta of 1.58.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The company had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. During the same quarter last year, the business earned $0.60 earnings per share. athenahealth’s revenue was up 10.1% on a year-over-year basis. equities research analysts expect that athenahealth will post 1.22 earnings per share for the current fiscal year.

In other news, Director David Eric Robinson sold 5,000 shares of athenahealth stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $133.94, for a total transaction of $669,700.00. Following the sale, the director now directly owns 8,596 shares of the company’s stock, valued at $1,151,348.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy Abernethy sold 500 shares of athenahealth stock in a transaction dated Tuesday, December 26th. The shares were sold at an average price of $134.18, for a total value of $67,090.00. Following the sale, the director now directly owns 4,045 shares in the company, valued at $542,758.10. The disclosure for this sale can be found here. Insiders have sold 69,700 shares of company stock worth $9,375,172 over the last three months. Insiders own 3.20% of the company’s stock.

Several institutional investors have recently bought and sold shares of ATHN. First Trust Advisors LP acquired a new position in shares of athenahealth in the second quarter worth approximately $219,000. Legal & General Group Plc lifted its stake in athenahealth by 11.2% in the second quarter. Legal & General Group Plc now owns 14,358 shares of the health services provider’s stock valued at $2,018,000 after buying an additional 1,444 shares during the period. BNP Paribas Arbitrage SA lifted its stake in athenahealth by 123.8% in the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock valued at $189,000 after buying an additional 744 shares during the period. Prudential Financial Inc. lifted its stake in athenahealth by 4.9% in the second quarter. Prudential Financial Inc. now owns 2,146 shares of the health services provider’s stock valued at $302,000 after buying an additional 100 shares during the period. Finally, Teachers Advisors LLC lifted its stake in athenahealth by 4.3% in the second quarter. Teachers Advisors LLC now owns 74,015 shares of the health services provider’s stock valued at $10,403,000 after buying an additional 3,072 shares during the period.

COPYRIGHT VIOLATION WARNING: “athenahealth (ATHN) Research Coverage Started at Evercore ISI” was reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/01/18/athenahealth-athn-research-coverage-started-at-evercore-isi.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

The Fly

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.